학술논문
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
Document Type
Article
Author
Source
In: Journal of the American Academy of Dermatology . (Journal of the American Academy of Dermatology, June 2024, 90(6):1190-1199)
Subject
Language
English
ISSN
10976787
01909622
01909622